Metreleptin for treating lipodystrophy

Equality Impact Assessment (Guidance development) (PDF 157 KB)

Final evaluation determination

Committee papers (PDF 7.96 MB)

Public committee slides (PDF 1.9 MB)

Final evaluation determination document (PDF 383 KB)

Appeal

Appeal

Aegerion : Appeal letter (PDF 384 KB)

Lipodystrophy UK : Appeal letter (PDF 772 KB)

Aegerion : Scrutiny letter (PDF 320 KB)

Lipodystrophy UK : Scrutiny letter (PDF 423 KB)

Aegerion : Response to scrutiny letter (PDF 341 KB)

NICE HST committee : Written submission (PDF 256 KB)

NICE Vice Chair : NICE's final response (PDF 262 KB)

Evaluation consultation: 1

Evaluation consultation document (PDF 373 KB)

Public committee slides (PDF 17.94 MB)

Committee papers (PDF 37.72 MB)

NICE's response to comments on the draft scope and provisional matrix (PDF 445 KB)

Equality Impact Assessment (Guidance development) (PDF 173 KB)

Final scope (PDF 215 KB)

Final matrix (PDF 253 KB)

Draft scope pre referral (PDF 218 KB)

Draft matrix pre referral (PDF 254 KB)